CIK: 1314821 - Address: C/o Osi Pharmaceuticals, Inc., 420 Saw Mill River Rd., Ardsley, NY 10502
12 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
3/3/10 19:05
3/1/10
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticLundemose Anker Md, Ph.D, DscNYOEVP,CorpM.d92132.64028999%31D
3/3/10 19:05
3/1/10
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticLundemose Anker Md, Ph.D, DscNYOEVP,CorpS.d-1,61255.200-29-4931D
2/5/09 17:11
2/3/09
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticLundemose Anker Md, Ph.D, DscNYOEVP,P OSM.d6029.7702828
2/5/09 17:11
2/3/09
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticLundemose Anker Md, Ph.D, DscNYOEVP,P OSS.d-8341.250-2-728
11/12/08 16:09
11/11/08
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticLundemose Anker Md, Ph.D, DscNYOEVP,P OSS-13839.530-4-1421D
12/20/07 15:22
12/19/07
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticLundemose Anker Md, Ph.D, DscNYOEVP,P OSS-12550.000-3-925D
10/29/07 13:42
10/26/07
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticLundemose Anker Md, Ph.D, DscNYOEVP,P OSS-10040.000-3-1121D
6/15/07 17:15
6/1/07
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticLundemose Anker Md, Ph.D, DscNYOEVP,P OSS-3837.660-1-423D
5/2/07 12:45
5/1/07
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticLundemose Anker Md, Ph.D, DscNYOEVP,P OSS-3534.800-1-424D
4/4/07 13:16
4/2/07
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticLundemose Anker Md, Ph.D, DscNYOEVP,P OSS-3333.130-1-425D
3/2/07 09:18
3/1/07
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticLundemose Anker Md, Ph.D, DscNYOEVP,P OSS-3433.990-1-426D
2/5/07 13:33
2/1/07
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticLundemose Anker Md, Ph.D, DscNYOEVP,P OSS-3434.030-1-427D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact